The research team, led by Martin Vychopen of University Hospital Leipzig together with colleagues including neuroradiologist Karl-Titus Hoffmann and neurosurgeons Erdem Güresir and Johannes Wach, pooled data from six randomized controlled trials encompassing up to 3,044 patients treated for ruptured intracranial aneurysms. Rather than simply averaging outcomes across all patients, as many earlier meta-analyses have done, the investigators stratified their analysis by aneurysm location and by the neurological severity of the hemorrhage at admission, measured on the World Federation of Neurosurgical Societies scale. This anatomically informed approach matters because an aneurysm tucked into the delicate branches of the middle cerebral artery presents a fundamentally different surgical and endovascular challenge than one sitting on the internal carotid artery near the skull base.

The headline finding concerns functional outcome at one year, assessed with the modified Rankin Scale, the standard yardstick of disability after stroke. When the researchers defined a favorable outcome as a score of 0 to 2, meaning the patient is independent in daily life, coiling came out clearly ahead. Across the pooled cohort of 3,044 patients, the odds of achieving independence at one year were 60 percent higher after endovascular coiling than after microsurgical clipping, an odds ratio of 1.60 with a 95 percent confidence interval of 1.36 to 1.88 and a p-value below 0.00001. Critically, heterogeneity across the six trials was essentially zero, indicating that the trials told a remarkably consistent story despite spanning more than two decades of practice.

But here is where the analysis turns provocative. When the team re-ran the numbers using a broader cut-off, defining favorable outcome as a modified Rankin Scale score of 0 to 3, the statistically significant advantage of coiling evaporated entirely. In that analysis of 2,278 patients from three trials, the odds ratio shrank to 1.19 with a p-value of 0.12, well short of significance. The implication is striking: much of the celebrated benefit of coiling may hinge on where exactly the disability scale is divided. This echoes long-standing critiques of the original International Subarachnoid Aneurysm Trial, or ISAT, whose landmark 2005 result established coiling as the preferred treatment in many centers worldwide. Commentators had previously argued that the binary 0-to-2 versus 3-to-6 split was insufficiently sensitive, and the new pooled data, which incorporate the more recent ISAT-2 trial by Darsaut and colleagues, lend quantitative weight to that concern.

The location-specific results are arguably the most clinically actionable part of the study. For aneurysms of the internal carotid artery, coiling delivered a decisive advantage in functional outcome, with an odds ratio of 0.44 favoring coiling, a difference that was highly significant with a p-value below 0.00001 and zero heterogeneity. The authors attribute this to the particular hazards of microsurgical access in this territory: internal carotid artery aneurysms, especially those arising at the ophthalmic segment or the carotid bifurcation, sit in a region where achieving proximal control of the vessel during open surgery can be difficult and may require additional measures to reduce blood flow, raising the morbidity of the surgical approach.

In contrast, no significant difference in one-year functional outcome emerged for aneurysms of the anterior cerebral artery and anterior communicating artery, the middle cerebral artery, or the posterior circulation. For anterior communicating aneurysms, which frequently rupture at small sizes and are associated with complex anatomy such as hypoplasia of the A1 segment, the pooled data support an individualized, anatomy-based decision rather than a default preference for either technique. For posterior circulation aneurysms, which carry elevated in-hospital mortality and a higher incidence of acute hydrocephalus, the analysis was limited by the underrepresentation of basilar and cerebellar aneurysms in prospective randomized trials, a caveat the authors acknowledge openly.

Where clipping decisively reasserts itself is in the durability of aneurysm closure. When the researchers examined complete occlusion confirmed on angiography twelve months after treatment, pooling four trials and 1,889 patients, surgical clipping was clearly superior, with an odds ratio of 0.35, a 95 percent confidence interval of 0.28 to 0.44, and again no heterogeneity. This overall effect, however, was driven almost entirely by one subgroup: middle cerebral artery aneurysms, where the odds of complete occlusion after clipping were more than five times those after coiling, an odds ratio of 5.21 with a p-value of 0.007. For internal carotid, anterior cerebral, and posterior circulation aneurysms, complete occlusion rates did not differ significantly between the two modalities. The anatomical explanation is compelling: middle cerebral artery aneurysms often resemble complex bifurcation lesions rather than simple sacs, frequently involving wide necks and critical branch vessels, and clipping in this location allows the surgeon to preserve distal flow while minimizing the risk of injury to small perforating arteries.

Why does complete occlusion matter so much? Because an incompletely closed aneurysm can reopen, and a reopened aneurysm can bleed again, sometimes catastrophically. The ARETA study found that roughly 20 percent of coiled aneurysms exhibit reopening or neck remnants, with about half of those requiring retreatment, while the CARAT investigation linked the risk of early rebleeding directly to the degree of aneurysm occlusion achieved. The Barrow Ruptured Aneurysm Trial further demonstrated that complete clip occlusion offers superior treatment durability, significantly reducing the need for repeat procedures, and both endovascular and microsurgical retreatment carry higher perioperative complication rates than the original intervention. Achieving complete obliteration in a single procedure therefore remains one of the central therapeutic goals in this disease.

Mortality, meanwhile, refused to pick a side. Across six trials and 2,921 patients, all-cause mortality did not differ between coiling and clipping, with an odds ratio of 0.89 and a p-value of 0.35. The severity-stratified analysis added another layer: among patients with good clinical grades, defined as WFNS grade 3 or better, coiling was associated with significantly better functional outcomes across 2,213 patients, whereas among the 168 patients with the worst grades, WFNS greater than 3, neither technique showed a significant advantage, likely reflecting the dominant influence of the initial brain injury itself on prognosis in severely affected patients.

The authors are careful about the limits of their work. The included trials span more than two decades, during which both endovascular devices and microsurgical techniques have evolved considerably, and modern adjuncts such as the Woven EndoBridge device and stent-assisted coiling are not yet represented in randomized subgroup data. Patients with posterior circulation aneurysms and high-grade hemorrhage remain underrepresented, and complete occlusion was a secondary endpoint in the original trials rather than a pre-specified primary one, introducing the possibility of distribution bias since aneurysm location was not randomly balanced across treatment arms. Risk-of-bias assessment using the Cochrane 2.0 tool rated ISAT and the Barrow Ruptured Aneurysm Trial as low risk across all domains, while other trials raised concerns ranging from unclear randomization to selective reporting. Even so, the core message stands with unusual clarity for a field long divided by tribal loyalties: for a ruptured internal carotid artery aneurysm, the catheter likely holds the edge in preserving independence at one year; for a ruptured middle cerebral artery aneurysm, the clip remains the gold standard for sealing the lesion completely and durably; and for everything in between, the decision deserves to be made aneurysm by aneurysm, patient by patient, balancing the promise of functional recovery against the imperative of permanent closure.

Subject of Research: Comparative effectiveness of endovascular coiling versus microsurgical clipping for ruptured intracranial aneurysms

Article Title: Efficacy and safety of endovascular coiling compared to microsurgical clipping in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of randomized trials

Article References: Vychopen, M., Hoffmann, K.-T., Güresir, E., & Wach, J. (2026). Efficacy and safety of endovascular coiling compared to microsurgical clipping in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of randomized trials. Journal of Neurology, 273(10), Article 650. https://doi.org/10.1007/s00415-026-14150-z

Image Credits: AI Generated

DOI: 10.1007/s00415-026-14150-z

Keywords: aneurysmal subarachnoid hemorrhage, endovascular coiling, microsurgical clipping, intracranial aneurysm, meta-analysis, randomized controlled trials, modified Rankin Scale, middle cerebral artery, internal carotid artery, complete occlusion, ISAT, neurosurgery

The rationale for the study rests on a well-documented but poorly understood phenomenon. As people age, total cerebral blood flow and the brain vessels’ ability to respond to metabolic demands both decline, and these declines independently predict higher dementia risk even after accounting for other cardiovascular factors. At the same time, aging vasculature accumulates oxidative stress, an imbalance between reactive oxygen species and the body’s antioxidant defenses. Excess reactive oxygen species degrade nitric oxide, the signaling molecule that blood vessel linings use to relax and widen. If oxidative stress is indeed strangling the aging brain’s arteries, then flooding the system with a potent antioxidant should, in principle, loosen the grip.

To test that idea, the team recruited generally healthy young adults aged 18 to 29 and middle-aged and older adults aged 55 to 79 from the Newark, Delaware area, excluding smokers, pregnant or breastfeeding women, and anyone with cardiovascular, neurological, autoimmune, or major psychiatric conditions. Each participant completed two laboratory visits separated by at least four days, receiving an intravenous ascorbic acid infusion on one occasion and a saline placebo on the other, in a randomly assigned order. The dosing protocol, adapted from earlier vascular aging studies, delivered a priming bolus of 0.06 grams of vitamin C per kilogram of fat-free mass over 20 minutes, followed by a continuous drip of 0.02 grams per kilogram maintained until all post-infusion measurements were complete. In a small subset where blood samples survived analysis, serum vitamin C levels rose roughly sevenfold, from about 1.2 to 8.6 milligrams per deciliter, confirming the infusion pushed concentrations well above physiological norms.

The study’s centerpiece was a clever probe of cerebrovascular endothelial function. When carbon dioxide in the blood rises abruptly, vessels downstream of the internal carotid artery dilate, increasing turbulent flow and shear stress along the carotid wall. That shear stress triggers the endothelium to release nitric oxide, which widens the artery further. By using a dynamically controlled gas delivery system to raise participants’ end-tidal carbon dioxide by 9 millimeters of mercury for just 30 seconds, and imaging the internal carotid artery with high-resolution duplex ultrasound, the researchers could quantify how well the extracranial vessel lining responded to a nitric oxide–dependent stimulus. Before infusion, this response was significantly blunted in the older group: relative internal carotid artery reactivity averaged about 3.4 percent in young adults versus roughly 3.0 percent or lower in the middle-aged and older group, with the deficit most pronounced in the vitamin C visit’s baseline measurements.

After the vitamin C infusion, the picture changed markedly for the older participants. Their relative internal carotid artery reactivity rose significantly, and the absolute diameter change climbed from a mean of about 0.056 millimeters to 0.32 millimeters, effectively erasing the age gap with the young group. In striking contrast, the same participants showed no such improvement after saline, and the young adults’ responses were essentially flat regardless of which infusion they received. This pattern, improvement only where function was impaired, is exactly what the pharmaco-dissection approach predicts if oxidative stress is suppressing nitric oxide–mediated dilation in aged vessels. Notably, the carbon dioxide stimulus itself was matched across conditions, with end-tidal changes of roughly 8 to 9 millimeters of mercury in every group and time point, so the differences could not be attributed to unequal challenges.

The researchers also examined the middle cerebral artery, an intracranial vessel whose response to sustained, three-minute hypercapnia is far less dependent on nitric oxide. Using transcranial Doppler ultrasound, they measured blood velocity and, by normalizing to beat-by-beat mean arterial pressure, calculated cerebrovascular conductance. At baseline, older adults showed significantly lower conductance-based reactivity than young adults. Vitamin C infusion again improved middle cerebral artery reactivity in the older group, whether expressed as velocity change or conductance change, while saline did not. The authors suggest this intracranial effect likely operates through different pathways than the carotid response, potentially involving pH regulation, red blood cell ATP release, potassium and calcium channels, prostaglandins, or reactive oxygen species acting directly as vasodilators. The precise mechanism, they caution, remains unresolved.

Not every measurement cooperated with the tidy narrative. Total cerebral blood flow, estimated from internal carotid and vertebral artery flows, was unexpectedly higher in the older group than the young group before infusion, contradicting the large body of literature showing age-related declines. The authors note that women in their sample, who tend to have higher cerebral blood flow, made up 71 percent of the older subgroup with usable data versus 44 percent of the young subgroup, and that global flow estimates cannot capture regional perfusion differences. Vitamin C did not significantly alter total cerebral blood flow in either age group. Meanwhile, brachial artery flow-mediated dilation, the standard test of peripheral endothelial function, was lower in older adults at baseline but showed only a non-significant trend toward improvement after vitamin C. In a small subset with paired data, peripheral and cerebral endothelial responses were uncorrelated, suggesting the two beds reflect distinct endothelial physiology and should not be treated as interchangeable windows on vascular health.

The study’s limitations are considerable and the authors are candid about them. Sample sizes were small and varied across outcomes, with complete internal carotid data available for only 10 to 11 participants per infusion visit and middle cerebral artery data for 17 to 20. A freezer malfunction destroyed most serum samples, preventing direct measurement of oxidative stress markers or nitric oxide metabolites in the full cohort, which means the proposed mechanism remains inferential. The transcranial Doppler technique assumes the middle cerebral artery does not itself dilate during hypercapnia, an assumption challenged by MRI studies. No comparable vasodilatory control condition was included, so the effect cannot be definitively pinned to nitric oxide–dependent pathways. And the analysis relied on pre-specified contrasts without multiple-testing correction, appropriate for hypothesis-driven designs but demanding cautious interpretation.

Even with those caveats, the central result stands out for its clarity: antioxidant-responsive mechanisms appear to be implicated in age-related impairments of both extracranial and intracranial cerebrovascular reactivity. The authors are careful to stress that this was a mechanistic experiment, not a therapy trial, and that nothing in the data supports self-treatment with high-dose vitamin C. Oral supplementation cannot reproduce the serum concentrations achieved intravenously, and whether repeated infusions would produce lasting benefit, or whether improved reactivity translates into preserved cognition, are questions for future studies with larger and more diverse cohorts. What the trial does establish is a model: a safe, reversible intervention that selectively restores cerebrovascular function in older adults, giving researchers a tool to dissect the redox pathways that may one day be targeted to keep aging brains well perfused.

Subject of Research: Effects of intravenous ascorbic acid infusion on age-related cerebrovascular dysfunction in adults

Article Title: Supraphysiological ascorbic acid infusion attenuates cerebrovascular dysfunction in middle‐aged and older adults

Article References: DeConne, T. M., Sanjana, F., Habash, E. M., Decker, K. P., Nichols, W., Hobson, J. C., Rizzi, N. A., & Martens, C. R. (2026). Supraphysiological ascorbic acid infusion attenuates cerebrovascular dysfunction in middle‐aged and older adults. Physiological Reports, 14(19), Article e71120. https://doi.org/10.14814/phy2.71120

Image Credits: AI Generated

DOI: 10.14814/phy2.71120

Keywords: ascorbic acid, cerebrovascular reactivity, vascular aging, oxidative stress, nitric oxide, cerebral blood flow, internal carotid artery, middle cerebral artery, hypercapnia, endothelial function, dementia risk, randomized crossover trial

The research, led by Chuanghui Zhou and Mengting Hu of Southwest Hospital at Army Medical University in Chongqing, China, together with colleagues, set out to answer a deceptively simple question: when you measure a narrowed brain artery with different imaging tools, which tool tells the truth? To find out, the team turned to digital subtraction angiography, or DSA, the long-standing gold standard for assessing blood vessels in the brain. DSA involves threading a catheter into the arterial system, injecting contrast dye directly into the cerebral circulation, and capturing X-ray images in real time. Because it shows contrast flowing through the vessel lumen with exceptional clarity, DSA remains the benchmark against which every non-invasive technique must ultimately be judged, even though it is invasive and carries its own small risks.

The study enrolled 115 patients with non-cardioembolic ischemic stroke, meaning strokes not caused by clots originating in the heart, who were evaluated between September 2022 and September 2025. From this group, the researchers identified 122 stenotic lesions in the middle cerebral artery. Each patient underwent both computed tomography angiography, or CTA, and high-resolution vessel wall imaging on a 7-Tesla MRI scanner. Two blinded radiologists then independently measured the severity of each narrowing, both by diameter and by cross-sectional area, as well as the length of the diseased segment. Blinding is critical in this kind of validation work: if the readers had known what the other modality or the reference standard showed, their measurements could have been unconsciously biased toward agreement.

The technical logic behind the comparison deserves attention. CTA estimates stenosis by imaging contrast-filled blood vessels with X-rays, producing bright, high-contrast pictures of the lumen that can be reconstructed into multiplanar and curved planar views. MRI vessel wall imaging at 7 Tesla works differently. The ultra-high magnetic field delivers a dramatically stronger signal and finer spatial resolution, allowing radiologists to visualize not just the channel through which blood flows but the vessel wall itself, where atherosclerotic plaque accumulates. This matters because the conventional method for grading stenosis, derived from the Warfarin-Aspirin Symptomatic Intracranial Disease trial, compares the narrowest residual lumen diameter with a reference diameter, and small measurement errors at the narrowest point are amplified into large errors in the calculated percentage of stenosis.

When the researchers compared each technique against DSA using the concordance correlation coefficient, a statistic that captures both precision and accuracy, the results favored the ultra-high-field scanner. For diameter-based stenosis measurements, CTA achieved a concordance correlation coefficient of 0.81, while 7-Tesla high-resolution vessel wall imaging reached 0.92. Bland-Altman analysis, which plots the differences between two measurement methods against their average to reveal systematic and proportional bias, told a similar story. CTA showed a mean bias of 0.06 with 95 percent limits of agreement spanning from minus 0.04 to 0.15, whereas the 7-Tesla technique showed a tighter mean bias of 0.02 with limits of agreement from minus 0.07 to 0.10. In plain terms, the MRI measurements clustered more closely around the values that DSA would have produced.

Lesion length, a variable that increasingly influences treatment decisions because long segments of disease may be less suitable for stenting or other endovascular interventions, showed an even more striking gap. The concordance correlation coefficient for length was 0.91 for CTA and 0.94 for vessel wall imaging, but the agreement limits diverged sharply. CTA measurements deviated from DSA by a mean of 0.48 millimeters, with 95 percent limits of agreement stretching from minus 2.35 to 1.40 millimeters. The 7-Tesla MRI measurements showed a mean bias of just 0.03 millimeters, with limits of agreement of minus 1.49 to 1.57 millimeters. For a neurointerventionalist planning a procedure inside an artery only a few millimeters wide, a two-millimeter uncertainty about where the disease begins and ends is not a trivial margin.

The study also explored an alternative way of quantifying narrowing. Instead of the traditional diameter-based calculation, the researchers measured the cross-sectional area of the stenotic lumen on both CTA and MRI and asked how well those area-based values correlated with the diameter-based stenosis percentages derived from DSA. The correlations were strong for both modalities, with Spearman correlation coefficients of 0.79 for CTA and 0.90 for high-resolution vessel wall imaging, both statistically significant. This finding supports the idea that area-based assessment, which some investigators argue better reflects the hemodynamic burden of a stenosis because flow capacity depends on the cross-sectional area of the vessel rather than a single linear diameter, could become a meaningful complement to conventional grading in intracranial disease.

Reproducibility, the question of whether different observers and the same observer on different days will produce the same numbers, is where the new technique truly distinguished itself. Intraclass correlation coefficients for inter-observer and intra-observer agreement ranged from 0.83 to 0.97 for CTA and from 0.94 to 0.99 for 7-Tesla vessel wall imaging. Values approaching 1.0 indicate near-perfect consistency, and the MRI figures sit at the very top of that range. In clinical practice, high reproducibility translates directly into confidence: when two specialists independently grade the same artery and reach the same conclusion, treatment decisions rest on firmer ground, and when a patient is followed over time, true progression of disease can be distinguished from measurement noise.

The implications reach beyond the radiology reading room. Current guidelines for symptomatic intracranial atherosclerotic disease hinge on stenosis severity, with aggressive medical management for most patients and consideration of endovascular treatment in selected severe cases. If the imaging that feeds those decisions underestimates or overestimates the narrowing, patients may be steered toward the wrong therapy. A non-invasive modality that matches the accuracy of catheter angiography could, in principle, spare some patients an invasive diagnostic procedure while giving clinicians richer information about plaque burden and vessel wall pathology that DSA, which shows only the lumen, cannot provide. The 7-Tesla scanner’s ability to image the arterial wall directly opens a window onto the biology of the plaque itself, including features associated with vulnerability and future stroke risk.

Important caveats remain before ultra-high-field MRI can reshape routine stroke care. Seven-Tesla scanners are expensive, less widely available than 1.5- or 3-Tesla systems, and subject to stricter safety screening because of their powerful magnetic fields. The study was retrospective, conducted at a single center with dedicated 7-Tesla infrastructure and specialist support, including collaboration with an industry MR research team, and its findings will need confirmation in broader, multicenter populations. The authors report no competing interests, and the work received support from dedicated 7-Tesla magnetic resonance research funds at Army Medical University. Still, the message of the validation is clear and, for a field that has long accepted the compromises of 3-Tesla imaging, quietly revolutionary: at 7 Tesla, non-invasive vessel wall imaging can measure brain artery narrowing with an accuracy and consistency that rivals, and in several respects exceeds, the CT angiography standard, bringing medicine a step closer to diagnosing the deadliest blockages without a single catheter entering the body.

Subject of Research: Validation of 7-Tesla high-resolution vessel wall MRI against DSA for quantifying middle cerebral artery stenosis

Article Title: Accuracy of 7T high-resolution vessel wall imaging versus CTA in middle cerebral artery stenosis: a DSA-based validation study

Article References: Zhou, C., Hu, M., Xiao, C., Hsu, Y., Chen, W., Chen, P., Liu, H., He, M., & Chen, J. (2026). Accuracy of 7T high-resolution vessel wall imaging versus CTA in middle cerebral artery stenosis: a DSA-based validation study. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02864-5

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02864-5

Keywords: 7-Tesla MRI, vessel wall imaging, middle cerebral artery, intracranial stenosis, CT angiography, digital subtraction angiography, ischemic stroke, atherosclerosis, neuroradiology, stenosis grading, medical imaging, reproducibility